Literature DB >> 18432906

Proliferative assays for B cell function.

James J Mond1, Mark Brunswick.   

Abstract

This unit describes procedures for measuring the capacity of purified B cells to undergo proliferation. The method centers on the use of polyclonal stimulating agents (mitogens) because these agents stimulate the majority of B cells and because the alternative (measurement of antigen-induced proliferation) requires the laborious procedures of isolating antigen-specific B cells (which are otherwise present in too low a concentration in whole B cell populations). Cross-linking of the B cell antigen receptor, surface immunoglobulin (sIg), by specific antigen stimulates cells to proliferate prior to secreting Ig. For this purpose, monoclonal or heterologous affinity-purified anti-Ig antibodies are used. B cells can also be stimulated to proliferate by antigen-nonspecific reagents (mitogens), and it is also critical to study the role of these mitogens in B cell responses. Both of these systems have the advantage that the majority of B cells will be activated. The first basic protocol describes B cell proliferation induced by two commonly used stimulants--anti-Ig antibody (either anti-IgM or anti-IgD) and lipopolysaccharide (LPS)--as measured by incorporation of [3H]thymidine into dividing cells. Alternate protocols describe other commonly used mitogens as well as other means of measuring cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 18432906     DOI: 10.1002/0471142735.im0310s57

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  5 in total

1.  Infusion of ex-vivo expanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease.

Authors:  P Achita; D Dervovic; D Ly; J B Lee; T Haug; B Joe; N Hirano; L Zhang
Journal:  Clin Exp Immunol       Date:  2018-07-31       Impact factor: 4.330

2.  Envelope virus-mimetic nanovaccines by hybridizing bioengineered cell membranes with bacterial vesicles.

Authors:  Mengmeng Zhang; Lu Wang; Jinyao Liu; Yan Pang
Journal:  iScience       Date:  2022-05-30

3.  Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.

Authors:  Peter Garcia; Abigail Harrod; Shruti Jha; Jessica Jenkins; Alex Barnhill; Holden Lee; Merritt Thompson; Jordan Pringle Williams; James Barefield; Ashton Mckinnon; Persia Suarez; Ananya Shah; Angela J Lowrey; Gretchen L Bentz
Journal:  Antiviral Res       Date:  2021-02-10       Impact factor: 5.970

4.  Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.

Authors:  Sadia Salahuddin; Emma K Fath; Natalie Biel; Ashley Ray; C Randall Moss; Akash Patel; Sheetal Patel; Leslie Hilding; Matthew Varn; Tabithia Ross; Wyatt T Cramblet; Angela Lowrey; Joseph S Pagano; Julia Shackelford; Gretchen L Bentz
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

5.  β-Lactoglobulin Influences Human Immunity and Promotes Cell Proliferation.

Authors:  Chun San Tai; Yi Yun Chen; Wen Liang Chen
Journal:  Biomed Res Int       Date:  2016-11-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.